American International Group’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

American International Group’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,027	Closed	-$10K	–	3163
2017 Q1	$10K	Buy	3,027 +200	+7%	+$946	﹤0.01%	2990
2016 Q4	$15K	Sell	2,827 -7	-0.2%	-$121	﹤0.01%	2980
2016 Q3	$71.4K	Buy	2,834 +4	+0.1%	+$101	﹤0.01%	2793
2016 Q2	$70K	Buy	2,830 +208	+8%	+$5.88K	﹤0.01%	2829
2016 Q1	$76K	Hold	2,622	–	–	﹤0.01%	3618
2015 Q4	$97K	Sell	2,622 -5	-0.2%	-$221	﹤0.01%	3511
2015 Q3	$128K	Buy	2,627 +3	+0.1%	+$210	﹤0.01%	3263
2015 Q2	$181K	Buy	+2,624	New	+$121K	﹤0.01%	3111

Other funds holding ANTH

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

American International Group's ANTH Position: Q2 2017 in Review

American International Group sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2017, closing a stake of 3,027 shares — an estimated $10K sold.

American International Group first reported a position in ANTH in Q2 2015 and held it in 8 quarters. The position peaked at $181K in Q2 2015. 40 funds tracked by Wall St. Rank hold ANTH as of Q2 2017.

American International Group reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
American International Group sold 3,027 Anthera Pharmaceuticals, Inc. shares in Q2 2017, an estimated $10K.
American International Group first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 8 quarters.
American International Group's Anthera Pharmaceuticals, Inc. position peaked at $181K in Q2 2015.
40 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2017.

Based on American International Group's 13F filing for Q2 2017, filed 11 Aug 2017.